Search within Newsroom University of Manchester
27 results found with keyword:
Aspergillosis
|
13
Jan
2024
|
00:07
Europe/London
The annual total of deaths from fungal disease worldwide has risen to 3.75 million, double the previous estimate, according to a new study. In a paper published in the leading journal Lancet Infectious Diseases, David Denning, a professor of infectious disease at The University of Manchester al ...
Read more
|
|
09
Jan
2024
|
09:51
Europe/London
An agricultural fungicide approved in the US and currently under consideration by authorities worldwide could have a devastating effect on a new drug for one of world’s deadliest infectious diseases, show University of Manchester scientists.Their Wellcome Trust funded study, published in Nature Mi ...
Read more
|
|
03
Jan
2023
|
14:32
Europe/London
Over fifty million Indians are affected by serious fungal disease, 10% of which are from potentially dangerous mould infections researchers from India and Manchester have shown.The experts from three Indian teaching hospitals: AIIMS, New Delhi, AIIMS Kalyani, West Bengal and PGIMER, Chandigarh along ...
Read more
|
|
25
May
2022
|
11:17
Europe/London
F2G, a University of Manchester spinout company, is to partner a major Japanese pharmaceutical company in the commercialisation of a novel antifungal treatment it developed for invasive aspergillosis and other rare mould infections.The partnership with Shionogi & Co brings the prospect of a viab ...
Read more
|
|
07
Dec
2021
|
11:28
Europe/London
A study of tuberculosis patients in six Jakarta hospitals has revealed up to 13 per cent of them had fungal lung infection – or aspergillosis – at the end of their treatment.The findings could, warn the research team from Universitas Indonesia and The University of Manchester, have impli ...
Read more
|
|
14
Jun
2021
|
16:07
Europe/London
Patients with a common respiratory disease had more flare-ups linked to activities that put them at risk of being exposed to mould in a study by University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) researchers.The study of 140 people with chronic obstructive pulmon ...
Read more
|
|
13
Oct
2020
|
13:07
Europe/London
000 to 1 million deaths annually, is a much larger problem than ever previously realised.Dr Caroline Baxter, Acting Clinical Director of the National Aspergillosis Centre, based at Wythenshawe Hospital, part of Manchester University NHS Foundation Trust said: “This is fantastic work by Emily a ...
Read more
|
|
23
Sep
2020
|
08:07
Europe/London
Around 550 million people have chronic obstructive pulmonary disease (COPD), according to two University of Manchester medical students.
The figure more than doubles the previous estimate of 251 million people with the illness linked to smoking by the World Health Organization (WHO) Global Burden ...
Read more
|
|
11
Sep
2020
|
11:12
Europe/London
tic test that uses pyrosequencing (a method of identifying genetic markers in DNA), to identify the right treatment for people with aspergillosis.
Aspergillosis is an infection caused by the Aspergillus mould. The disease is rare in healthy people but people with a weakened immune system, damaged ...
Read more
|
|
19
Mar
2019
|
15:00
Europe/London
Around 1 in 15 people affected by tuberculosis are likely get the treatable fungal infection aspergillosis according to new research by experts at The University of Manchester and Gulu Referral Hospital, Uganda.
The new knowledge could influence TB programs by helping doctors to identify – ...
Read more
|
